We recently published a paper comparing the incidence of adverse outcomes after unicompartmental and total knee arthroplasty (UKA and TKA). The conclusion of this study, which was in favour of UKA, was dismissed as "biased" in a review in Bone & Joint 360. Although this study is one of the least biased comparisons of UKA and TKA, this episode highlights the biases that exist both for and against UKA. In this review, we explore the different types of bias, particularly selection, reporting and measurement. We conclude that comparisons between UKA and TKA are open to bias. These biases can be so marked, particularly in comparisons based just on national registry data, that the conclusions can be misleading. For a fair comparison, data from randomised studies or well-matched, prospective observational cohort studies, which include registry data, are required, and multiple outcome measures should be used. The data of this type that already exist suggest that if UKA is used appropriately, compared with TKA, its advantages outweigh its disadvantages.
1
The conclusion of this study, which was in favour of UKA, was dismissed as "biased" in a review in Bone & Joint 360. 2 This was subsequently reprinted by The Bone & Joint Journal in the preliminary pages of the April 2015 issue. Although this study is one of the least biased comparisons of UKA and TKA, this episode highlights the biases that exist both for and against UKA. In this review, we explore the different sources of bias and how they might be avoided, based on our published paper, National Registry data and a metaanalysis of published data. 3 
Adverse outcomes study
Our study comparing the incidence of adverse outcomes following UKA and TKA was a matched study based on data from the National Joint Registry for England and Wales (NJR) and other large datasets. 1 The incidence of all adverse outcomes, except re-operation and revision, were lower following UKA. To put this in perspective we stated that "If 100 patients receiving TKA received UKA instead; the result would be around one less death and three more re-operations in the first four years after surgery". The Bone & Joint 360 review, with which no author was associated, dismissed this as "Bias in reporting? Quite possibly". 2 It also suggested that we should have made the comparison at an earlier time point, missing the point of the paper, which was a comparison of adverse outcomes not just immediately post-operatively, but also out to eight years. In fact, we chose the time point arguably least favourable to UKA. At an earlier stage, for example, at one year, both the death and the re-operation rates were less for UKA than for TKA. We did not quote the comparison at eight years as the numbers of patients with this length of follow-up was low, but if we had, the message would have been starker: "If 60 patients receiving TKA received UKA instead, the result would be around one less death and three more re-operations in the first eight years after surgery".
Perhaps the bias is not in the presentation, but in the data and the analysis? The data are, however, freely available, and standard and appropriate statistical techniques were used and we followed the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) guidelines for reporting of observational studies. 4 As it was not possible to answer our research question using a randomised controlled trial such as the Total or Partial Knee Arthroplasty Trial (TOPKAT), 5 due to the rarity of adverse events such as mortality, we used the next best study design, which is a prospective observational cohort study. The most important potential bias in this study, and in most comparative studies, is selection bias as TKA and UKA tend to be implanted in different groups of patients. To avoid this bias, we matched patients using propensity score analysis. 6 This provides balanced baseline characteristics in both groups. As every patient that had a UKA would have had a TKA had they been treated by a non-UKA surgeon, virtually all UKA patients were matched with TKA controls. In addition, all patients receiving TKA with no comparable UKA controls were eliminated. There are not enough data fields within the NJR to provide enough variables for adequate matching, thus we used data from multiple sources. Despite matching on over 20 variables, the groups may still have been inadequately matched. However, as discussed in our paper, this is unlikely to have affected the conclusions. Furthermore, another paper from the NJR based on the same data, and presented by a group with no known bias in favour of UKA, came to the same conclusion as we did about the short-term mortality rate. 
National registers
Due to the way national registers are set up, the interpretation of the data is usually biased against UKA. In every national register, the failure rate of UKA is about three times higher than that of TKA, so there is pressure on surgeons to avoid UKA. 9 This, we believe, is not justified because of selection, reporting and measurement bias. Selection bias occurs because UKA tend to be implanted in younger, fitter and more active patients than TKA and younger, fitter and more active patients tend to have higher revision rates. An indication of the size of the selection bias is that the difference in the revision rate between UKA and TKA is twice as high in NJR data as it is in the matched comparison using NJR and other data sets. 1 Reporting bias occurs because registries focus on only one outcome measure: revision surgery. UKA fare worse than TKA when revision is the outcome measure. However, with virtually all other outcome measures, UKA do better. 1, 10, 11 Therefore because of the reporting bias, registries focus on the disadvantages, and not the advantages, of UKA.
The main bias in national registries is measurement bias, because the decision to revise is influenced by the type of arthroplasty. 12 For example, as UKA is generally easier to revise than TKA, and the outcomes of revision are considered to be better, the threshold for revision is lower. 13 Therefore a UKA with a poor outcome will be more likely to be revised than a TKA with a similarly poor outcome. There is good evidence based on data from the New Zealand Joint Registry (NZJR) that this is one of the main reasons why UKA has a higher revision rate than TKA. 13 The NZJR, as well as collecting data about revision, also collects Oxford Knee Scores (OKS) at six months following the operation and categorises the score into poor, fair, good and excellent. 14, 15 This demonstrates that UKA provides 30% more 'excellent' results, whereas TKA have 60% more 'poor' results. (Findings supported by data from other studies). 13, 10 Therefore the higher revision rate cannot be considered to be a reflection of poorer results from UKA. The NZJR also compares the six-month OKS with the subsequent revision rate. Whatever the outcome score, the revision rate of UKA is about five times higher than that of TKA. 13, 14 Thus, factors independent of the early outcome score, such as the threshold for revision, increase the revision rate fivefold. The most striking difference in revision rate occurs in those patients who have failed to improve as a result of surgery, and who have a worse score post-than pre-operatively (largely those with a post-operative OKS less than 20). These patients have a 10% chance of being revised if they have had a TKA and a 60% chance of being revised if they have had a UKA. 13, 14 This illustrates why revision is an unsatisfactory outcome measure due to measured bias. Following TKA only a small proportion of patients that have failed to benefit from the arthroplasty are revised, whereas following UKA, the majority are revised. As a result, a comparison of UKA with TKA based on revision rates is misleading, as it suggests that UKA have more 'poor' outcomes than TKA, when the data suggests that they have less.
The NJR has recently stated that comparisons between UKA and TKA should not be based on revision rate alone. 16 It therefore seems inappropriate that the identification of surgeon outliers is based on revision rate, and it is assumed the revision rate of UKA and TKA should be the same. The primary method used to identify an outlier is the funnel plot of all knee replacements based on the combined revision rate of UKA and TKA. As the revision rate of UKA is higher than TKA, surgeons who perform UKA are likely to appear worse on the funnel plot than those that do not. Furthermore, surgeons who perform UKA are more likely to be outliers, and outliers are more likely to be surgeons who perform UKA. We are aware of a number of surgeons who are outliers for all replacements combined, yet are average for both UKA and TKA when these are analysed separately. These surgeons are being put under pressure to stop being outliers, and the only way they can rapidly do this is to stop doing UKA. There is a simple solution: in the analysis for the combined funnel plot, adjustments should be made based on the average revision rate of UKA and TKA. 17 Following these adjustments, surgeons that have an average revision rate for both UKA and TKA separately would have an average revision rate on the combined funnel plot and would not be outliers. The outlier system would then only identify surgeons with truly bad results, whether they use UKA or not, and would encourage them to improve their results of UKA and TKA, rather than encouraging them to stop undertaking UKA.
Meta-analysis
A meta-analysis of the results of the Oxford UKA (ZimmerBiomet, United Kingdom) published in 2011 illustrates other biases and misunderstandings associated with UKA.
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In this meta-analysis, compared with the designer surgeons, the revision rate was four times higher in registry data and three times higher in independent series. The authors state that "the cause of this divergence can only be an issue for speculation". We find it surprising that the authors did not consider the explanation of their findings to be obvious. The results of knee arthroplasty depend not only on the implant, but also on the indications and surgical technique. It is for this reason there are large discrepancies between the results for the same implant in different registries. For example, the Repicci UKA (Biomet, Warsaw, Indiana) was the best performing UKA in Australia were actually better than those of the designers, although, for some reason, these results were not included in the meta-analysis. Furthermore, since its publication, 3 at least nine other series have been published or presented, which quote the ten-year survival of the Phase 3 Oxford UKA. 21 The implant survival rates from the designer surgeons 22 and the independent surgeons were similar. It would therefore seem that if surgeons adhere to the recommended indications and techniques, they might reasonably expect to achieve results similar to the designer surgeons. Conversely, if they do not do this their results probably will be worse. The indications for the Oxford UKA are clearly defined and are satisfied in up to 50% of the patients requiring knee arthroplasty. 23 Analysis of NJR data has shown that the best results with the Oxford UKA are achieved when surgeons use it for between 20% and 50% of their knee arthroplasties. 24 It has also shown that most surgeons use the Oxford UKA in less than 10% of their knee arthroplasties and have worse results. This suggests that many surgeons do not apply the recommended indications. The solution seems simple: if surgeons want to use the Oxford UKA, or, presumably, other UKA, they should follow the recommended indications. They would then be undertaking UKA on appropriate patients, and would be doing enough to gain the necessary experience to achieve good results.
Conclusion
Comparisons between UKA and TKA are open to bias. This is particularly marked in comparisons based solely on national registry revision rates. In these circumstances, the selection, reporting and measurement biases are so great that the conclusions may be misleading. Therefore, it is not appropriate to use these analyses to compare UKA and TKA. Furthermore, when identifying surgeon outliers, it is not appropriate to assume the revision rate of UKA and TKA should be the same. For a fair comparison of UKA and TKA, data from randomised controlled trials or wellmatched prospective observational cohort studies are required, and multiple outcome measures should be used which could include adverse events, patient reported outcome measures and cost-effectiveness. Very few studies of this type exist, and the data that are available suggest that the advantages of UKA outweigh the disadvantages. 1, 10, 11, 25, 26 This therefore supports the increased use of UKA. This would be best achieved by surgeons, who undertake small numbers of UKA, using the recommended indications and techniques and, therefore, undertaking greater numbers and getting better results.
Take home message:
Comparisons between unicompartmental and total knee arthroplasty are open to bias and often misleading; reliable comparisons require randomised controlled trials or well-matched observational cohort studies. The author or one or more of the authors have received or will receive benefits for personal or professional use from a commercial party related directly or indirectly to the subject of this article. In addition, benefits have been or will be directed to a research fund, foundation, educational institution, or other nonprofit organisation with which one or more of the authors are associated.
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